source
- Outpace Bio halts Phase 1 ovarian cancer CAR‑T trialOutpace Bio announced that it has stopped its Phase 1 trial of OPB-101, an autologous CAR‑T therapy targeting mesothelin in ovarian cancer. The company said the trial will no longer enroll patient…
- RFK Jr. campaigns in Iowa as healthcare companies prepare earnings reportsRobert F. Kennedy Jr. appeared in Iowa to support GOP gubernatorial candidate Zach Lahn, marking his final push on the campaign trail. The week’s agenda also includes earnings calls from major hea…